What is the bull case here?
MHRA approval without reiumbursement is not going to stop the dilution and likelihood of that approval happening is zero to none in the current form of their submission. It is probably going to increase it. There is still is no path to profitability. Have they started a submission to a market where they can actually achieve profit (ie FDA or EMA or Japan)? 2.7B share authorized now....Think about it $1 Per share is 2.7B market cap. You can't get a 2.7B market cap without any sales.....kiss $1 a share goodbye. This company is so capped out now.....cents is the top. I'm shocked this thing in the .20s....but not for long.
I don't know who they think they they are fooling. This submission is almost 2 years old. SMFH, it ain't happened by now, then it ever happening. That is the reality of the situation. They can go ahead and try and argue for their tainted trial results without letting shareholders updated. If it was important then they should have designed a proper trial and re-run it, but they didn't. Can anyone actually believe it is getting approved 2 years since submission (701 days and counting)? All this other talk is just distraction....who GAF about SOW 8...Update shareholders about the only thing that matters .....
They are desperate with the unleashing of their Pump Crew Social Media ........
Market Data 
Markets 
AI
